Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time?

Publication type:
Journal article
Metadata:
Autoren
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000895616800001&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.3390/ph15111387
eISSN
1424-8247
Externe Identifier
  • Clarivate Analytics Document Solution ID: 6W3FM
  • PubMed Identifier: 36355558
Ausgabe der Veröffentlichung
11
Zeitschrift
PHARMACEUTICALS
Schlüsselwörter
  • addiction
  • aromatherapy
  • antiviral activity
  • inflammation
  • opioid crisis
  • pain
Artikelnummer
ARTN 1387
Datum der Veröffentlichung
2022
Status
Published
Titel
Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time?
Sub types
  • Review
Ausgabe der Zeitschrift
15

Data source: Web of Science (Lite)

Other metadata sources:
Abstract
<jats:p>The active compounds from essential oils have been an important asset in treating different diseases for many centuries. Nowadays, there are various available formulations used as food supplements to stimulate the immune system. In light of the current pandemic and the large amount of fake news circulating the internet, it is important to analyze which of the active compounds from essential oils can be successfully used in the treatment of COVID-19 infections. We analyzed the current literature on the effects of essential oils against the new SARS-CoV-2 virus to gain a better understanding of the underlying mechanisms of these compounds and establish their possible antiviral efficacy. The available studies have highlighted the antiviral potential of active compounds from essential oils, indicating that they could be used as adjuvants in treating various viral infections, including COVID-19, leading to a milder course of the disease, and improving patients’ outcomes. At the same time, these compounds relieve pain and lift the mood in comorbid patients suffering from opioid addiction. Essential oils might be useful as adjuvant tools, not only against SARS-CoV-2 but also for a subset of especially vulnerable patients affected with both COVID-19 and opioid addiction. However, randomized clinical trials are needed to determine their efficacy and develop standardized high-quality preparations that can be safely administered to the general population.</jats:p>
Autoren
DOI
10.3390/ph15111387
eISSN
1424-8247
Ausgabe der Veröffentlichung
11
Zeitschrift
Pharmaceuticals
Sprache
en
Online publication date
2022
Paginierung
1387 - 1387
Status
Published online
Herausgeber
MDPI AG
Herausgeber URL
http://dx.doi.org/10.3390/ph15111387
Datum der Datenerfassung
2023
Titel
Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time?
Ausgabe der Zeitschrift
15

Data source: Crossref

Abstract
The active compounds from essential oils have been an important asset in treating different diseases for many centuries. Nowadays, there are various available formulations used as food supplements to stimulate the immune system. In light of the current pandemic and the large amount of fake news circulating the internet, it is important to analyze which of the active compounds from essential oils can be successfully used in the treatment of COVID-19 infections. We analyzed the current literature on the effects of essential oils against the new SARS-CoV-2 virus to gain a better understanding of the underlying mechanisms of these compounds and establish their possible antiviral efficacy. The available studies have highlighted the antiviral potential of active compounds from essential oils, indicating that they could be used as adjuvants in treating various viral infections, including COVID-19, leading to a milder course of the disease, and improving patients' outcomes. At the same time, these compounds relieve pain and lift the mood in comorbid patients suffering from opioid addiction. Essential oils might be useful as adjuvant tools, not only against SARS-CoV-2 but also for a subset of especially vulnerable patients affected with both COVID-19 and opioid addiction. However, randomized clinical trials are needed to determine their efficacy and develop standardized high-quality preparations that can be safely administered to the general population.
Addresses
  • Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.
Autoren
DOI
10.3390/ph15111387
eISSN
1424-8247
Externe Identifier
  • PubMed Identifier: 36355558
  • PubMed Central ID: PMC9693097
Funding acknowledgements
  • Deutsche Forschungsgemeinschaft: GRK2015/2
Open access
true
ISSN
1424-8247
Ausgabe der Veröffentlichung
11
Zeitschrift
Pharmaceuticals (Basel, Switzerland)
Sprache
eng
Medium
Electronic
Online publication date
2022
Open access status
Open Access
Paginierung
1387
Datum der Veröffentlichung
2022
Status
Published
Publisher licence
CC BY
Datum der Datenerfassung
2022
Titel
Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time?
Sub types
  • review-article
  • Review
  • Journal Article
Ausgabe der Zeitschrift
15

Files

https://www.mdpi.com/1424-8247/15/11/1387/pdf?version=1668670042 https://europepmc.org/articles/PMC9693097?pdf=render

Data source: Europe PubMed Central

Abstract
The active compounds from essential oils have been an important asset in treating different diseases for many centuries. Nowadays, there are various available formulations used as food supplements to stimulate the immune system. In light of the current pandemic and the large amount of fake news circulating the internet, it is important to analyze which of the active compounds from essential oils can be successfully used in the treatment of COVID-19 infections. We analyzed the current literature on the effects of essential oils against the new SARS-CoV-2 virus to gain a better understanding of the underlying mechanisms of these compounds and establish their possible antiviral efficacy. The available studies have highlighted the antiviral potential of active compounds from essential oils, indicating that they could be used as adjuvants in treating various viral infections, including COVID-19, leading to a milder course of the disease, and improving patients' outcomes. At the same time, these compounds relieve pain and lift the mood in comorbid patients suffering from opioid addiction. Essential oils might be useful as adjuvant tools, not only against SARS-CoV-2 but also for a subset of especially vulnerable patients affected with both COVID-19 and opioid addiction. However, randomized clinical trials are needed to determine their efficacy and develop standardized high-quality preparations that can be safely administered to the general population.
Date of acceptance
2022
Autoren
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/36355558
DOI
10.3390/ph15111387
Externe Identifier
  • PubMed Central ID: PMC9693097
Funding acknowledgements
  • Deutsche Forschungsgemeinschaft: GRK2015/2
ISSN
1424-8247
Ausgabe der Veröffentlichung
11
Zeitschrift
Pharmaceuticals (Basel)
Schlüsselwörter
  • addiction
  • antiviral activity
  • aromatherapy
  • inflammation
  • opioid crisis
  • pain
Sprache
eng
Country
Switzerland
PII
ph15111387
Datum der Veröffentlichung
2022
Status
Published online
Titel
Can Essential Oils Provide an Alternative Adjuvant Therapy for COVID-19 Infections and Pain Management at the Same Time?
Sub types
  • Journal Article
  • Review
Ausgabe der Zeitschrift
15

Data source: PubMed

Beziehungen:
Property of

Tools